Praxis Medical Insights

High-Risk Populations

Severe anemia is a major risk factor for intradialytic hypotension in dialysis patients, affecting those with hemoglobin levels significantly below target, according to the National Kidney Foundation 1
Anemic dialysis patients experience exaggerated drops in blood pressure during ultrafiltration due to impaired vascular responsiveness, as reported by the American Society of Nephrology 1
Predialysis systolic blood pressure <100 mmHg combined with anemia creates particularly high risk for symptomatic hypotension during dialysis, as noted by the National Kidney Foundation 1
Older adults (≥65 years) with anemia are at increased risk for hypotension, particularly those with multiple comorbidities, according to the American Geriatrics Society 1
Age-related impairment in vascular responsiveness combined with anemia-induced vasodilation increases vulnerability to low blood pressure in elderly patients, as reported by the American Geriatrics Society 1

Anemia forces cardiac compensation through increased heart rate and stroke volume, which adds hemodynamic stress to already compromised hearts, as stated by the European Society of Cardiology 2
The combination of anemia and heart disease creates a vicious cycle where anemia worsens cardiac function, and cardiac dysfunction impairs tissue perfusion, potentially manifesting as hypotension, according to the European Society of Cardiology 2
Anemia is present in approximately 50% of heart failure patients and is associated with substantially decreased aerobic capacity and functional status, as reported by the American College of Cardiology 2 and the European Society of Cardiology 4
Check hemoglobin levels in all patients with hypotension who have underlying heart failure, kidney disease, or liver disease, as recommended by the American College of Physicians 3
Assess for specific hemodynamic patterns, including measuring blood pressure in supine and standing positions to detect orthostatic changes, as suggested by the European Society of Cardiology 2

Never use erythropoiesis-stimulating agents (ESAs) for anemia in patients with heart disease, as they increase thrombotic events including stroke and provide no mortality benefit, according to the American College of Cardiology 4
Avoid aggressive transfusion strategies—use a restrictive threshold of 7-8 g/dL if transfusion becomes necessary, as liberal transfusion provides no benefit and may worsen heart failure, as reported by the American College of Physicians 3
For iron deficiency anemia with heart failure, use intravenous iron (ferric carboxymaltose) rather than oral iron, which improves exercise capacity, quality of life, and reduces heart failure hospitalizations (RR 0.74), as recommended by the American College of Cardiology 4
Target hemoglobin of 110 g/L (11 g/dL) in chronic kidney disease patients, with an acceptable range of 100-120 g/L, as suggested by the National Kidney Foundation 5
In dialysis patients with intradialytic hypotension and anemia, optimize ultrafiltration rates and consider dialysate temperature modeling to reduce hemodynamic stress, as recommended by the American Society of Nephrology 1